Lentiviral-mediated Gene Therapy for Pediatric Patients With Fanconi Anemia Subtype A
Trial details
- Registry ID
- NCT04069533
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Lentiviral-mediated Gene Therapy for Pediatric Patients With Fanconi Anemia Subtype ANCT04069533 | RCKT | Phase 2 | Unknown | 2025-02Estimated |
| Gene Therapy for Fanconi Anemia, Complementation Group ANCT04248439 | RCKT | Phase 2 | Active not recruiting | 2026-05-05Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |